leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 00:34:25 - browse：14696

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Prior authorization reform is both possible and imperative

focus

Wikipedia

WSS

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Pumping milk in bathrooms at health conferences is common

Mass General, Mayo Clinic look to monetize custom

FDA endorses new sterilization method for medical devices

Dana Farber says 6 studies to be retracted and 31 corrected

Congress needs to close a vaccine

hotspot

leisure time

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Senators tussle over abortion against the backdrop of a presidential campaign

Dobbs anniversary: the lost opportunity of abortion as health care

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Duchenne breakthrough therapy leaves behind pioneering families

Eli Lilly’s Zepbound improved liver scarring in mid

In Memoriam: Notable people who died in 2023

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Future doctors need a strong humanities education

leisure time

ASCO Takeaways: Winners, snoozers, and the art of cancer care

CMS got Medicare Advantage quality rating wrong, judge rules

High breast density mammograms need follow

There's an unseen cost to disruptive road

Anthony Fauci pushes back on GOP claims during Covid hearing

Head of FDA's diagnostics center, who led through Covid, retires

focus

Wikipedia

knowledge

entertainment